These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7709704)

  • 1. Immunosuppressive therapy in inflammatory bowel disease.
    Hoang P; Fontaine P; Dalton HR; Gehenot M; Sibille C; Schoonbroodt D; Vanheuverzwyn R
    Acta Gastroenterol Belg; 1994; 57(5-6):333-8. PubMed ID: 7709704
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 3. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 4. Position statement: immunomodulator therapy for inflammatory Bowel disease.
    Lavy A; Chowers Y; Odes HS; Eliakim R;
    Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of conventional immunosuppressive drugs in IBD.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Zippi M
    Dig Liver Dis; 2004 Nov; 36(11):766-80. PubMed ID: 15571009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: monitoring of immunomodulators in inflammatory bowel disease.
    Aberra FN; Lichtenstein GR
    Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of immunosuppressors in chronic inflammatory intestinal diseases].
    Lémann M
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B178-88. PubMed ID: 10897790
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R; Horgan K
    Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
    Su C; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General principles of medical therapy of inflammatory bowel disease.
    Friedman S
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive agents: Imurel and Purinethol].
    Groupe d'étude thérapeutique des affections inflammatoires digestives
    Rev Prat; 2005 May; 55(9):994. PubMed ID: 16052970
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard immunosuppression in IBD: current practice.
    Feagan BG
    Acta Gastroenterol Belg; 2001; 64(2):182-8. PubMed ID: 11475131
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance in inflammatory bowel diseases.
    Moreau J; Mas E
    Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: immunosuppressive therapy for inflammatory bowel disease.
    Kozarek RA
    Aliment Pharmacol Ther; 1993 Apr; 7(2):117-23. PubMed ID: 8485264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine and mercaptopurine: lymphoma.
    Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.